IDV vehicle
36E79720D0070
NEW CONTRACT AWARD ONTRUZANT(TRASTUZUMAB) 150MG WITH MERCK FOR A BASE PLUS FOUR ONE YEAR OPTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $22.6M |
| Start date | Nov 15, 2020 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Jan 27, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 27, 2025 | P00022 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE A CHANGE IN THE ADMINISTRATIVE POINT OF CONTACT FOR ORGANON LLC. |
| Jan 23, 2025 | P00021 | $0 | THIS MODIFICATION IS BEING ISSUED TO INCORPORATE ORGANON LLC SUBCONTRACTING PLAN. |
| Nov 21, 2024 | P00020 | $0 | INCORPORATION OF 2025 FEDERAL CEILING PRICES INTO CONTRACT. NATIONAL CONTRACT PRICES REMAIN UNCHANGED. |
| Oct 3, 2024 | P00019 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE THE FOURTH OPTION YEAR WITH ORGANON. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.